Animal model review finds adolescent cannabis exposure interacts with early-life stress to increase schizophrenia-like outcomes
A review of animal models found adolescent cannabinoid exposure combined with early-life adversity (particularly maternal deprivation and maternal immune activation) produced synergistic schizophrenia-like effects, with important sex differences.
Quick Facts
What This Study Found
When adolescent cannabinoid exposure was combined with early-life adversity in animal models, patterns of synergistic and protective effects emerged. Models incorporating maternal deprivation and maternal immune activation showed the most consistent synergistic effects with adolescent cannabinoid exposure. Sex-specific effects were commonly observed.
Key Numbers
Multiple models reviewed. Most consistent synergistic effects: maternal deprivation + adolescent cannabinoids, and maternal immune activation + adolescent cannabinoids. Sex differences frequently observed.
How They Did This
Review evaluating animal models that combine adolescent cannabinoid exposure with other schizophrenia risk factors (maternal deprivation, maternal immune activation, social isolation, genetic models). Behavioral, cognitive, and morphological outcomes assessed.
Why This Research Matters
Schizophrenia results from multiple interacting risk factors. Understanding which combinations amplify risk most could guide targeted prevention for high-risk adolescents.
The Bigger Picture
The "two-hit" hypothesis of schizophrenia gains support: early-life adversity may prime the brain for vulnerability, and adolescent cannabis exposure then acts as a second hit to trigger the illness.
What This Study Doesn't Tell Us
Animal models use synthetic cannabinoids at standardized doses; human cannabis exposure is more variable; not all combinations of risk factors have been tested; sex differences need more systematic study.
Questions This Raises
- ?Could adolescents with histories of early-life adversity be specifically counseled about cannabis risk?
- ?Would neuroprotective interventions in early life prevent the synergistic effect?
Trust & Context
- Key Stat:
- Maternal deprivation and immune activation showed most consistent synergistic effects with adolescent cannabinoids
- Evidence Grade:
- Comprehensive review of preclinical models, though translation to human risk remains uncertain.
- Study Age:
- Published in 2020.
- Original Title:
- Adolescent cannabinoid exposure interacts with other risk factors in schizophrenia: A review of the evidence from animal models.
- Published In:
- Neuroscience and biobehavioral reviews, 116, 202-220 (2020)
- Authors:
- Dunn, Ariel L, Michie, Patricia T(3), Hodgson, Deborah M, Harms, Lauren
- Database ID:
- RTHC-02523
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Does childhood trauma make cannabis more dangerous for teenagers?
Animal models suggest yes. When early-life adversity (like maternal deprivation) was combined with adolescent cannabinoid exposure, the effects on schizophrenia-like behaviors were often greater than either factor alone.
Are boys and girls affected differently?
The review found sex-specific effects across multiple models, though the patterns were not always consistent. More research is needed to systematically characterize how sex influences the interaction between early-life adversity and adolescent cannabis exposure.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-02523APA
Dunn, Ariel L; Michie, Patricia T; Hodgson, Deborah M; Harms, Lauren. (2020). Adolescent cannabinoid exposure interacts with other risk factors in schizophrenia: A review of the evidence from animal models.. Neuroscience and biobehavioral reviews, 116, 202-220. https://doi.org/10.1016/j.neubiorev.2020.06.028
MLA
Dunn, Ariel L, et al. "Adolescent cannabinoid exposure interacts with other risk factors in schizophrenia: A review of the evidence from animal models.." Neuroscience and biobehavioral reviews, 2020. https://doi.org/10.1016/j.neubiorev.2020.06.028
RethinkTHC
RethinkTHC Research Database. "Adolescent cannabinoid exposure interacts with other risk fa..." RTHC-02523. Retrieved from https://rethinkthc.com/research/dunn-2020-adolescent-cannabinoid-exposure-interacts
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.